113 related articles for article (PubMed ID: 11181943)
1. Selective dopamine receptor stimulation differentially affects [3H]arachidonic acid incorporation, a surrogate marker for phospholipase A2-mediated neurotransmitter signal transduction, in a rodent model of Parkinson's disease.
Hayakawa T; Chang MC; Rapoport SI; Appel NM
J Pharmacol Exp Ther; 2001 Mar; 296(3):1074-84. PubMed ID: 11181943
[TBL] [Abstract][Full Text] [Related]
2. D2 but not D1 dopamine receptor stimulation augments brain signaling involving arachidonic acid in unanesthetized rats.
Bhattacharjee AK; Chang L; Lee HJ; Bazinet RP; Seemann R; Rapoport SI
Psychopharmacology (Berl); 2005 Aug; 180(4):735-42. PubMed ID: 16163535
[TBL] [Abstract][Full Text] [Related]
3. Effects of intrastriatal injection of the dopamine receptor agonist SKF38393 and quinpirole on locomotor behavior in hemiparkinsonism rats.
Guo M; Xiang T; Li M; Sun Y; Sun S; Chen D; Jia Q; Li Y; Yao X; Wang X; Zhang X; He F; Wang M
Behav Brain Res; 2021 Aug; 411():113339. PubMed ID: 33945831
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway.
Yoshimura N; Kuno S; Chancellor MB; De Groat WC; Seki S
Br J Pharmacol; 2003 Aug; 139(8):1425-32. PubMed ID: 12922929
[TBL] [Abstract][Full Text] [Related]
5. Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons.
Ruskin DN; Bergstrom DA; Walters JR
J Neurophysiol; 2002 Jul; 88(1):487-96. PubMed ID: 12091570
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid incorporation depicts brain activity in a rat model of Parkinson's disease.
Hayakawa T; Chang MC; Bell JM; Seeman R; Rapoport SI; Appel NM
Brain Res; 1998 Oct; 807(1-2):177-81. PubMed ID: 9757030
[TBL] [Abstract][Full Text] [Related]
7. Chronic lithium chloride administration to unanesthetized rats attenuates brain dopamine D2-like receptor-initiated signaling via arachidonic acid.
Basselin M; Chang L; Bell JM; Rapoport SI
Neuropsychopharmacology; 2005 Jun; 30(6):1064-75. PubMed ID: 15812572
[TBL] [Abstract][Full Text] [Related]
8. Chronic d-amphetamine depresses an imaging marker of arachidonic acid metabolism in rat brain.
Bhattacharjee AK; Chang L; Chen M; White L; Bell JM; Bazinet RP; Rapoport SI
Int J Neuropsychopharmacol; 2008 Nov; 11(7):957-69. PubMed ID: 18570702
[TBL] [Abstract][Full Text] [Related]
9. In vivo imaging of disturbed pre- and post-synaptic dopaminergic signaling via arachidonic acid in a rat model of Parkinson's disease.
Bhattacharjee AK; Meister LM; Chang L; Bazinet RP; White L; Rapoport SI
Neuroimage; 2007 Oct; 37(4):1112-21. PubMed ID: 17681816
[TBL] [Abstract][Full Text] [Related]
10. Haloperidol downregulates phospholipase A(2) signaling in rat basal ganglia circuits.
Myers CS; Contreras MA; Chang MC; Rapoport SI; Appel NM
Brain Res; 2001 Mar; 896(1-2):96-101. PubMed ID: 11277978
[TBL] [Abstract][Full Text] [Related]
11. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
[TBL] [Abstract][Full Text] [Related]
12. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
Sonsalla PK; Manzino L; Heikkila RE
J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
[TBL] [Abstract][Full Text] [Related]
13. Effects of the intrastriatal administration of selective dopaminergic agonists on Fos expression in the rat brain.
Blandini F; Fancellu R; Orzi F; Conti G; Greco R; Tassorelli C; Nappi G
Neurol Sci; 2002 Sep; 23 Suppl 2():S57-8. PubMed ID: 12548342
[TBL] [Abstract][Full Text] [Related]
14. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
Huang KX; Bergstrom DA; Ruskin DN; Walters JR
Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
[TBL] [Abstract][Full Text] [Related]
15. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
16. Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease.
Lindgren HS; Ohlin KE; Cenci MA
Neuropsychopharmacology; 2009 Nov; 34(12):2477-88. PubMed ID: 19606087
[TBL] [Abstract][Full Text] [Related]
17. D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism.
Ballion B; Frenois F; Zold CL; Chetrit J; Murer MG; Gonon F
Neurobiol Dis; 2009 Sep; 35(3):376-84. PubMed ID: 19501163
[TBL] [Abstract][Full Text] [Related]
18. Chronic levodopa treatment alters basal and dopamine agonist-stimulated cerebral glucose utilization.
Engber TM; Susel Z; Kuo S; Chase TN
J Neurosci; 1990 Dec; 10(12):3889-95. PubMed ID: 1980132
[TBL] [Abstract][Full Text] [Related]
19. Imaging apomorphine stimulation of brain arachidonic acid signaling via D2-like receptors in unanesthetized rats.
Bhattacharjee AK; Chang L; White L; Bazinet RP; Rapoport SI
Psychopharmacology (Berl); 2008 May; 197(4):557-66. PubMed ID: 18274730
[TBL] [Abstract][Full Text] [Related]
20. Requirement for the endocannabinoid system in social interaction impairment induced by coactivation of dopamine D1 and D2 receptors in the piriform cortex.
Zenko M; Zhu Y; Dremencov E; Ren W; Xu L; Zhang X
J Neurosci Res; 2011 Aug; 89(8):1245-58. PubMed ID: 21557291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
